tiprankstipranks
The Fly

Intensity Therapeutics reports Q3 EPS (25c), consensus (30c)

Intensity Therapeutics reports Q3 EPS (25c), consensus (30c)

As of September 30, cash and cash equivalents totaled $2.8M, which the company expects will be sufficient to fund operations into the first quarter in 2025.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Questions or Comments about the article? Write to editor@tipranks.com